Drug Topics

AUGUST 15, 2024

New prices will go into effect on January 1, 2026, for individuals covered by Medicare Part D prescription drugs.

198

198

STAT

AUGUST 15, 2024

WASHINGTON — The day drug makers dreaded has finally arrived.  Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them.  The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl

145

145

Drug Topics

AUGUST 15, 2024

A CDC report called for “increased efforts” to ensure parents can obtain all recommended vaccines for their eligible children and realize the full potential of the VFC program.

Vaccines 112

Vaccines 112

STAT

AUGUST 15, 2024

Modern medicine has an empathy problem. Artificial intelligence — done right — might be able to help ease it. Despite the proliferation of communication training programs over the past decade or two, doctors often fail to express empathy, especially in stressful moments when patients and their families are struggling to hear bad news and make difficult decisions.

Communication 142

Communication Patient Care 142

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

AUGUST 15, 2024

The supplemental biologics license application was granted based on results from the ADRIATIC phase 3 trial among individuals with limited stage small cell lung cancer.

FDA 130

FDA 130

STAT

AUGUST 15, 2024

As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions because Medicare doesn’t sufficiently cover far more convenient, and less distressing, at-home treatments with the arthritis drug Humira. When rheumatoid arthritis patients enroll in Medicare, switching from private insurance plans, self-administered medications such as Humira and Xeljanz become unaffordable overnight, thanks to the program’s convoluted pricing of at

Insurance 141

Insurance Hospitals 141

STAT

AUGUST 15, 2024

The National Institutes of Health said Thursday that an antiviral often used to treat mpox did not resolve patients’ symptoms faster than placebo in a randomized trial. The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe.

144

144

Fierce Healthcare

AUGUST 15, 2024

The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations. | The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations.

133

133

STAT

AUGUST 15, 2024

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I’m really excited to see “Alien: Romulus” this weekend, which I’m told harkens back to the 1979 original. Great 1970s-era sci-fi movies and TV series that are not Star Wars: Space 1999, Battlestar Galactica, Planet of the Apes, Close Encounters of the Third Kind, and Logan’s Run.

137

137

Pharmacy Times

AUGUST 15, 2024

Key opinion leaders analyze the efficacy, safety profile, and proper utilization of behind-the-counter medications such as pseudoephedrine products, exploring their mechanisms of action and potential adverse effects, while also providing strategies for pharmacists to identify contraindications, drug interactions, and appropriate dosing regimens for these medications.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

AUGUST 15, 2024

When demand for office space cratered during the Covid-19 pandemic, many developers in the Boston area doubled down on building lab space instead. Lately, it sure seems like they went overboard. With life sciences buildings hitting the market at a much faster rate than they can be filled, the region’s lab vacancy rate has skyrocketed, to the point that the share of empty space available rivals that of the pandemic-battered office market.

127

127

pharmaphorum

AUGUST 15, 2024

AI's role in inventing new drugs raises questions about ownership rights in the pharmaceutical sector. Explore the complexities of defining ownership in drug discovery with AI technology.

115

115

STAT

AUGUST 15, 2024

Lykos Therapeutics, whose MDMA-assisted psychotherapy for post-traumatic stress disorder was rejected late last week by U.S. regulators, announced Thursday that it would cut 75% of its staff, and that the company’s founder would step down from its board. “We take to heart the FDA’s decision and the additional work we will need to do to bring this pioneering therapy to market,” Jeff George, chairman of the board, said in a statement.

FDA 123

FDA 123

Pharmacy Times

AUGUST 15, 2024

The new prices are expected to go into effect for patients with Medicare Part D on January 1, 2026.

149

149

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

AUGUST 15, 2024

The U.S. Department of Health and Human Services has stated it will do all that it can to mitigate the health care industry’s greenhouse gas emissions. The evidence suggests it is climate washing. Climate washing is defined as a government or business providing inadequate, inaccurate, misleading, or false public information about its climate policy ambitions or implementation efforts to reduce greenhouse gas emissions, especially when the claims are made without independent third-party as

Communication 123

Communication 123

Fierce Pharma

AUGUST 15, 2024

Just as a new strain of mpox spreads across Africa, results from a preliminary analysis of a study that began during the 2022 viral outbreak stands to provide more clarity on the clinical benefit o | Despite missing the trial's primary endpoint of time to lesion resolution, the study suggested that the treatment may be most beneficial for those treated early and those with severe disease.

117

117

STAT

AUGUST 15, 2024

A widespread, monthslong contract dispute between UnitedHealthcare and Trinity Health has created a confusing patchwork of disrupted access across multiple states.  UnitedHealthcare is the country’s largest health insurer, so its contract disagreements with large health systems affect members across the country from one another, threatening access to dozens of hospitals and their affiliated physicians.

Hospitals 116

Hospitals Insurance 116

Drug Topics

AUGUST 15, 2024

As the role of pharmacists continues to change, new digital tools can help improve medication adherence and patient outcomes.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

AUGUST 15, 2024

Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the | Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the original lawsuit.

113

113

STAT

AUGUST 15, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Big news this morning, so let’s get straight into it.

Vaccines 113

Vaccines 113

Fierce Healthcare

AUGUST 15, 2024

Information services company Wolters Kluwer rolled out new digital solutions to help retail pharmacies go paperless in an online, mobile tech consumer world. | There is a need to revamp the retail pharmacy experience beyond providing patients with medication leaflets. Two new pharmacy solutions offer digital health content to provide pharmacy consumers with accessible medication and health information.

128

128

Drug Topics

AUGUST 15, 2024

Community pharmacies in counties with high racialized economic segregation had higher odds of restricting buprenorphine.

Community Pharmacies 112

Community Pharmacies 112

STAT

AUGUST 15, 2024

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Almost exactly two years ago, the Inflation Reduction Act was signed into law, allowing Medicare to negotiate drug prices for the first time. Today, the agency announced how much it lowered the costs for 10 drugs in the first year of negotiation.

109

109

Pharmacy Times

AUGUST 15, 2024

Building off the positive results of ELM-1, the ELM-2 trial found intravenously administered odronextamab was safe and effective in patients with relapsed or refractory follicular lymphoma.

139

139

STAT

AUGUST 15, 2024

Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And what would you name a commercial psychotherapy treatment? We discuss all that and more on this week’s episode of “The Readout LOUD.

FDA 107

FDA 107

pharmaphorum

AUGUST 15, 2024

FDA clears Incyte's potential blockbuster Niktimvo as a treatment for chronic GvHD, making it a companion to the company's Jakafi for the disorder.

FDA 109

FDA 109

Pharmacy Times

AUGUST 15, 2024

Some individuals are still unaware of the significance of routine oral hygiene and its link to overall health

122

122

pharmaphorum

AUGUST 15, 2024

AstraZeneca's plan to invest £450m in a vaccines plant in the UK has been thrown into doubt by a bid to slash state aid, reports FT

Vaccines 113

Vaccines 113

Fierce Pharma

AUGUST 15, 2024

So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. | So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. While neither recall has resulted in any safety flags or side effect reports so far, the issues stemming from the faulty products could be severe, the drugmakers have w

FDA 97

FDA 97

pharmaphorum

AUGUST 15, 2024

FDA approves Gilead's Livdelzi for primary biliary cholangitis, setting up a contest with Ipsen's recent launch Iqirvo in the second-line setting

FDA 104

FDA 104

Outsourcing Pharma

AUGUST 15, 2024

Tonix Pharmaceuticals has announced promising phase 3 trial results for TNX-102 SL (sublingual cyclobenzaprine HCl), a treatment targeting fibromyalgia.

105

105

PharmaVoice

AUGUST 15, 2024

A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.

96

96

Outsourcing Pharma

AUGUST 15, 2024

Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has announced a significant expansion of its clinical manufacturing services at its small molecules site in Bend, Oregon.

97

97